Cargando…
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions
The National Heart, Lung, and Blood Institute–funded National MDS Natural History Study (NCT02775383) is a prospective cohort study enrolling patients with cytopenia with suspected myelodysplastic syndromes (MDS) to evaluate factors associated with disease. Here, we sequenced 53 genes in bone marrow...
Autores principales: | DeZern, Amy E., Goll, Johannes B., Lindsley, R. Coleman, Bejar, Rafael, Wilson, Steffanie H., Hebert, Donnie, Deeg, Joachim, Zhang, Ling, Gore, Steven, Al Baghdadi, Tareq, Maciejewski, Jaroslaw, Liu, Jane, Padron, Eric, Komrojki, Rami, Saber, Wael, Abel, Gregory, Kroft, Steven H., Harrington, Alexandra, Grimes, Tyler, Reed, Harrison, Fulton, Robert S., DiFronzo, Nancy L., Gillis, Nancy, Sekeres, Mikkael A., Walter, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368770/ https://www.ncbi.nlm.nih.gov/pubmed/36947201 http://dx.doi.org/10.1182/bloodadvances.2022008578 |
Ejemplares similares
-
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
por: Gorak, Edward J., et al.
Publicado: (2023) -
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes
por: Radakovich, Nathan, et al.
Publicado: (2021) -
COVID-19 Outcomes Among Participants in the NHLBI Myelodysplastic Syndromes (MDS) Natural History Study
por: Padron, Eric, et al.
Publicado: (2021) -
Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
por: Ramaswamy, Kavitha, et al.
Publicado: (2022) -
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
por: Versluis, Jurjen, et al.
Publicado: (2022)